149 related articles for article (PubMed ID: 36621381)
21. Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
Thai AA; Young RJ; Bressel M; Angel C; McDowell L; Tiong A; Bucknell NW; Fellowes A; Xu H; Trigos A; Rischin D; Solomon BJ
Br J Dermatol; 2023 Oct; 189(5):588-602. PubMed ID: 37470440
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma.
Wang W; Ollila HM; Whittemore AS; Demehri S; Ioannidis NM; Jorgenson E; Mignot E; Asgari MM
Cancer Immunol Immunother; 2018 Jul; 67(7):1123-1133. PubMed ID: 29754218
[TBL] [Abstract][Full Text] [Related]
23. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma.
Cañueto J; Martín-Vallejo J; Cardeñoso-Álvarez E; Fernández-López E; Pérez-Losada J; Román-Curto C
Clin Exp Dermatol; 2018 Dec; 43(8):876-882. PubMed ID: 29756221
[TBL] [Abstract][Full Text] [Related]
24. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of advanced cutaneous squamous cell carcinoma.
Dessinioti C; Pitoulias M; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
[TBL] [Abstract][Full Text] [Related]
26. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
27. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
[TBL] [Abstract][Full Text] [Related]
28. Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients.
Genders RE; Osinga JAJ; Tromp EE; O'Rourke P; Bouwes Bavinck JN; Plasmeijer EI
Acta Derm Venereol; 2018 Jun; 98(6):551-555. PubMed ID: 29405246
[TBL] [Abstract][Full Text] [Related]
29. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
31. Rate and Characteristics of Incompletely Excised Cutaneous Squamous Cell Carcinoma: A Dermatological Daily Practice Multicenter Prospective Cohort Study.
van Lee CB; Kouloubis N; Wakkee M; Kelleners-Smeets NWJ; Nellen RGL; van Rengen A; de Vijlder HC; Wijne LCC; Nijsten T; van den Bos RR
Dermatol Surg; 2022 Dec; 48(12):1269-1273. PubMed ID: 36194767
[TBL] [Abstract][Full Text] [Related]
32. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
[TBL] [Abstract][Full Text] [Related]
36. Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients.
Ilyas M; Zhang N; Sharma A
Dermatol Surg; 2018 Mar; 44(3):370-374. PubMed ID: 29517497
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study.
Granger EE; Groover M; Harwood C; Proby CM; Karn E; Murad F; Schmults CD; Ruiz ES
J Am Acad Dermatol; 2024 Apr; 90(4):731-738. PubMed ID: 38043592
[TBL] [Abstract][Full Text] [Related]
38. Myosin18B predicts favorable prognosis of cutaneous squamous-cell carcinoma.
Cao C; Zhang C; Sun Y; Mu Z; Shen Q
Genes Genomics; 2021 Apr; 43(4):371-378. PubMed ID: 33555505
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients.
García-Díez I; Hernández-Muñoz I; Hernández-Ruiz E; Nonell L; Puigdecanet E; Bódalo-Torruella M; Andrades E; Pujol RM; Toll A
Genes Chromosomes Cancer; 2019 Mar; 58(3):164-174. PubMed ID: 30474248
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Saenz-Sardà X; Musulén E; Fuente MJ; Puig L
Arch Dermatol Res; 2022 Oct; 314(8):767-775. PubMed ID: 34647185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
